Investors : main shareholders include founders, business angels, Institut Pasteur, FAM-Midi-Pyrénées and EdRIP

BT PHARMA is a Limited Company under French law (Société Anonyme). It is managed by an Executive Management Board (Directoire). The  Executive Management Board is controlled by a Supervisory Board of Directors (Conseil de Surveillance) appointed by the General Assembly of shareholders.

Since its creation in 2001, the company has raised a total of € 9.3 million of which € 5.9 million in equity. Main shareholders include founders, business angels, Institut Pasteur, FAM-Midi-Pyrénées and Edmond de Rothschild Investment Partners (EdRIP).

BT PHARMA s.a.
Prologue-BioTech
Rue Pierre et Marie Curie BP 28262
31682 Labège-Innopole Cedex
France

BT PHARMA is registered at the Chamber of Commerce of Toulouse, France under
N° RGS B 439 489 022 – N° de gestion 2001 B 2036
Code APE : 73.1 Z
N° VAT (TVA) : FR10 439 489 022

BT PHARMA is a privately traded, limited responsibility company with nominal equity of EUR 252 137. For more information CONTACT US.